N NEURODE
LIVE

Serial Number

79372000

Owner

Neurode Pty Ltd

Attorney

Janice Housey

Filing Date

May 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

N NEURODE Trademark

Serial Number: 79372000 • Registration: 7682949

N NEURODE is a trademark filed by Neurode Pty Ltd on May 17, 2023. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Neurode Pty Ltd

11A George St

Entity Type: 99

Trademark Details

Filing Date

May 17, 2023

Registration Date

February 11, 2025

Published for Opposition

December 24, 2024

Goods & Services

Medical services; medical diagnostic services in the nature of testing and analysis of cognitive performance for diagnosing and treating neurological conditions; medical counselling; medical clinic services; medical care services; medical service for the treatment of neurological conditions; medical neurology treatment services; providing medical information to patients and medical professionals in the form of reports in the field of neurology; providing medical information including online; provision of medical information; provision of medical treatment of neurological conditions; remote monitoring of medical data for medical diagnosis and treatment of neurological conditions; medical reporting services in the nature of preparation of medical reports; behavioural analysis for medical purposes; provision of information relating to behavioural modification for therapy or medical purposes; medical consultancy and advisory services; preparation of psychological profiles for medical purposes via a website that is designed to provide custom tailored outputs about recommended resources and treatments associated with neurological symptoms and concerns; lifestyle counselling in the form of psychological therapy for patients with neurological conditions; psychological testing for medical purposes; psychological counselling; ADHD screening services

Measuring devices for diagnosing and treating neurological conditions and monitoring cognitive performance used for medical purposes; measuring devices having digital displays for diagnosing and treating neurological conditions and monitoring cognitive performance for medical use; sensing devices for medical use in monitoring the vital signs of patients; apparatus for electrical muscle stimulation used for medical purposes; apparatus for the electrical stimulation of groups of muscles used for medical purposes; contact apparatus for deriving electrical signals from human bodies used for medical purposes; electric apparatus for therapeutic application to the body to improve cognitive performance for people with neurological conditions; electrical apparatus for analysis of cognitive behaviour used for medical purposes; electrical apparatus for medical diagnosis of neurological conditions; electrical apparatus for medical purposes for applying therapeutic stimulation to the body to improve cognitive performance for people with neurological conditions; electrical apparatus for medical treatment of neurological conditions; electrical appliances used for diagnosing and treating neurological conditions and monitoring cognitive performance for curative purposes; electrical appliances, namely, minimally invasive neurovascular devices for the diagnosis and treatment of neurological conditions and for monitoring cognitive performance for medical purposes; electrical machines, namely, headsets for use in treating neurological conditions of the human body; electrical nerve stimulators used for diagnosing and treating neurological conditions and monitoring cognitive performance; electrically operated medical apparatus used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulation electrodes used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulation instruments used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulators; transcutaneous electrical muscle stimulators used for diagnosing and treating neurological conditions and monitoring cognitive performance; analytical instruments, namely, headsets used for diagnosing and treating neurological conditions and monitoring cognitive performance for medical use; detecting instruments for cognitive performance for medical use; diagnostic instruments for neurological conditions for medical use; electro-medical diagnostic instruments used for diagnosing and treating neurological conditions and monitoring cognitive performance; instruments for diagnosis of neurological conditions for medical use

Software as a service (SaaS) featuring software for diagnosing and treating neurological conditions and monitoring cognitive performance; software as a service (SaaS) featuring software for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; online provision of temporary use of non-downloadable web-based applications for diagnosing and treating neurological conditions and monitoring cognitive performance ; online provision of temporary use of non-downloadable web-based applications for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; online provision of temporary use of non-downloadable web-based software for diagnosing and treating neurological conditions and monitoring cognitive performance ; online provision of temporary use of non-downloadable web-based software for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; design and development of computer software; consultancy in the design and development of computer software; computer security services in the nature of design and development of secure computer hardware, software and systems; development of computer software application solutions; providing information, including online, about design and development of computer hardware and software; research and development of new products for others; scientific research into the development of new products; technical research into the development of new products; advisory services relating to product testing; biotechnology testing for others in the field of neurology; platform as a service (PaaS) featuring computer software platforms for diagnosing and treating neurological conditions and monitoring cognitive performance; platform as a service (PaaS) featuring computer software platforms for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; development of computer platforms; creating and maintaining weblogs for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 27, 2025 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 25, 2025 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2025 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2024 TROA
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 14, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 14, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 22, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 15, 2023 REPR